✦ LIBER ✦

383 POSTER A phase 1 study of XL281, a potent and selective inhibitor of RAF kinases, administered orally to patients (pts) with advanced solid tumors

✍ Scribed by G.K. Schwartz; S. Yazji; D.S. Mendelson; M.A. Dickson; S.H. Johnston; E.W. Wang; P. Shannon; L. Pace; M.S. Gordon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

404 POSTER Pharmacodynamics (pd) of x188

✍ P. LoRusso; L. Appleman; A. Zhu; G. Shapiro; L. Fox; A. Wolanski; S. Hitchcock-B 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

97 POSTER A phase I dose-escalation stud

✍ K. Papadopoulos; J. Rodon; A. Mita; P. O'Rourke; A. Patnaik; E. Rubin; A. Tolche 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

342 POSTER A phase I dose-escalation and

✍ B.I. Sikic; H.A. Wakelee; A.A. Adjei; J. Halsey; J.L. Lensing; J.D. Dugay; L.J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

383 POSTER A Phase I Study of dasatinib,

✍ J. Morgan; G. Demetri; D. Wang; I. MacPherson; P. LoRusso; A. van den Abbeele; V 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 58 KB

218 POSTER A phase I dose-escalation stu

✍ E. Calvo; G. Edelman; J. Baselga; E. Kwak; C. Scheffold; L. Nguyen; G.I. Shapiro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

379 POSTER A phase I study of XL184, a M

✍ R. Kurzrock; S. Sherman; D. Hong; C. Ng; J. Frye; L. Janisch; M.J. Ratain; R. Sa 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 80 KB